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Objectives/Hypothesis: Identify predictors of decannulation failure after cricotracheal resection (CTR) and thyrotracheal
anastomosis (TTA) in patients with subglottic stenosis (SGS).
Study Design: Retrospective cohort study.
Methods: Charts of patients undergoing CTR and TTA for SGS at the University Health Network, Toronto, Ontario, Canada
between 1988 and 2017 were reviewed. Patient, pathology, treatment, and outcome data were collected. The end points for
statistical analysis were development of restenosis and permanent tracheostomy.
Results: One hundred fourteen patients (n = 114) were eligible for inclusion in this review. The mean age at primary
resection was 46.9 years, 95 (83%) were females, and 19 (17%) were males. The rate of restenosis and permanent tracheos-
tomy was 13% and 5%, respectively. Sixty-two patients (54%) underwent a CTR and TTA, and 52 patients (46%) underwent a
CTR, laryngofissure, and TTA. Traumatic stenosis (odds ratio [OR] = 10.3, P = .017), longer T-tube duration (OR = 1.2,
P = .011), combined glottic/subglottic stenosis (OR = 10.47, P = .010), start of the stenosis at the vocal cords (OR = 6.6,
P = .029), postoperative minor complications (OR = 13.6, P = .028), and need for repeat surgery (OR = 44.1, P < .001) were
associated with an increased risk of requiring permanent tracheostomy.
Conclusions: CTR and TTA are excellent surgical approaches for adult patients with subglottic stenosis. In this study, 5%
of patients required permanent tracheostomy. Factors predicting treatment failure include traumatic stenosis, longer T-tube
duration, combined glottic/subglottic stenosis, start of stenosis at the level of vocal cords, postoperative minor complications,
and need for repeat surgery.
Key Words: Adult subglottic stenosis, cricotracheal resection, prognostic factors.
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INTRODUCTION
Subglottic stenosis is a potentially life-threatening con-
dition. It is generally classified into congenital and acquired
etiologies. Laryngeal trauma and iatrogenic injuries, typi-
cally during intubation, are the most common underlying
etiology for adult subglottic stenosis.1 External trauma,
which can be either blunt or penetrating, is less often impli-
cated in the etiology of airway stenosis. In the remainder of
patients, the exact etiology is idiopathic in nature.2 The
subglottis and the posterior glottis are the two most com-
monly involved sites.3
The management of airway stenosis presents a major
therapeutic challenge. Treatment options vary depending
on the underlying etiology, severity of the condition, com-
orbidities, as well as patient’s wishes and expectations.
Management of airway stenosis is aimed at restoring all
forms of function leading to normal ventilation, speech, and
swallow. Many techniques have been described. These can
be broadly divided into endoscopic and external techniques.
The goal of these procedures is tomaximize the airway’s vol-
ume and to maintain this during the healing phase. Dilata-
tion, stenting, and surgical resection using both endoscopic
and external techniques have been used.4 The outcome of
the majority of the endoscopic techniques is temporary.
A permanent resolution will often require a more complex
open procedure during which the stenotic segment is
resected and reconstructed to maintain a functional, uncom-
promised airway.
There are limited data investigating predictors of
restenosis and decannulation failure in patients after
cricotracheal resection (CTR). Airway comorbidities (asthma,
chronic obstructive pulmonary disease [COPD], unilateral
vocal cord paralysis), postoperative complications, and length
of resection have previously been reported as risk factors for
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retreatment.5 In pediatric patients, severity of stenosis,
glottic involvement, and comorbidities are predictors of less
favorable outcomes.6
The objective of the study was to evaluate outcomes
and identify predictors of restenosis and decannulation
failure in adult patients with subglottic or upper tracheal
stenosis managed with CTR or tracheal resection.
MATERIALS AND METHODS
After institutional research ethics board approval, a retrospec-
tive reviewwas conducted of all patients who underwent surgery for
subglottic stenosis at the Toronto General Hospital, University
Health Network, Toronto, Ontario, Canada from January 1, 1988 to
July 1, 2017. Patients with isolated posterior glottic stenosis or
malignant pathology were excluded. Patient (gender, age, com-
orbidities), stenosis (symptoms, previous treatment, site, length,
grade), treatment (CTR and thyrotracheal anastomosis [TTA] 
laryngofissure, length resected, histopathology, time with T tube,
complications), and outcome data (restenosis rate, salvage surgery,
permanent tracheostomy, follow-up) were collected from the elec-
tronic patient records. Stenosis information, such as length and
TABLE I.
Patients’ Characteristics (N = 114).
Covariate Value
Sex
Female 95 (83)
Male 19 (17)
Age at surgery, yr
Mean (SD) 46.9 (13.2)
Median (minimum, maximum) 47.3 (12.4, 80)
Airway
Stridor 49 (43)
Tracheostomy dependent 28 (25)
Voice
Dysphonia 20 (18)
Acceptable 94 (82)
Idiopathic
No 51 (45)
Yes 63 (55)
History of airway trauma
No 107 (94)
Yes 7 (6)
Comorbidities
None 80 (70)
Yes 34 (30)
Length of stenosis, cm
Mean (SD) 2.2 (0.7)
Median (minimum, maximum) 2 (1, 4.5)
Missing 3
Length of resection, cm
Mean (SD) 2.9 (0.7)
Median (minimum, maximum) 3 (1, 5)
Missing 23
T-tube duration, d
Mean (SD) 65.1 (140.3)
Median (minimum, maximum) 43 (0, 1,451)
Tracheostomy
No 66 (58)
Yes 48 (42)
Prior endoscopic surgery
No 46 (40)
Yes 68 (60)
Prior external surgery
No 91 (80)
Yes 23 (20)
Diagnosis
Subglottic 91 (80)
Combined 21 (18)
Tracheal 2 (2)
Grade of stenosis
≤ 50% 43 (43)
51%–70% 32 (32)
71%–99% 21 (21)
100% 5 (5)
(Continues)
TABLE I.
Continued
Covariate Value
Missing 13
Start of stenosis
At vocal cord 17 (15)
Below 96 (85)
Missing 1
Procedure
CTR, LF, TTA 52 (46)
CTR, TTA 62 (54)
Pathology
Benign 3 (3)
Fibrosis, chronic inflammation 111 (97)
Complication
None 78 (68)
Major 16 (14)
Minor 20 (18)
Postoperative airway
None 14 (12)
T tube 92 (81)
Tracheostomy 8 (7)
Repeat surgery
No 98 (86)
Yes 16 (14)
Restenosis
No 99 (87)
Yes 15 (13)
Permanent tracheostomy
No 108 (95)
Yes 6 (5)
Data are presented as number (%) unless indicated otherwise.
CTR = cricotracheal resection; LF = laryngofissure; SD = standard
deviation; TTA = thyrotracheal anastomosis.
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grade of stenosis, were obtained from intraoperative description
when available. Our technique of CTR has been previously
reported.1 The area of stenosis was retrospectively graded using the
Cotton-Myer classification (grade 1, ≤50%; grade 2, 51%–70%; grade
3, 71%–99%; grade 4, 100%).7
Complications were defined as major if they required active
operative intervention or were life-threatening. Patients who
required further surgery for recurrent airway obstruction were
defined as having developed restenosis. Those who required a per-
manent tracheostomywere deemed to have failed therapy.
Patient factors, stenosis characteristics, and treatment fac-
tors potentially predictive for the development of restenosis or
the need for a permanent tracheostomy were analyzed using
logistic regression. Factors were tested one at a time for signifi-
cant effects using the Wald statistic, and P < .05 was deemed
statistically significant. All analyses were performed using
R software version 3.5.2 (The R Foundation for Statistical Com-
puting, Vienna, Austria).
RESULTS
Demographics
One hundred fourteen patients (n = 114) were included
in this review. Baseline characteristics are described in
Table I. The mean age at primary resection was 46.9 years
(standard deviation [SD] = 13.2, median = 47.3 [12.4–80]);
95 patients (83%) were females and 19 patients were males
(17%). We included one patient under the age of 18 years
(12.4) at time of treatment. The etiology of the stenosiswas idi-
opathic in 63 (55%) and traumatic in seven (6%) patients. Sig-
nificant comorbidities were present in 34 (30%) patients.
These included significant medical disorders ranging from
diabetes mellitus, chronic gastrointestinal disease, ischemic
heart disease, renal failure, and chronic airway limitation.
Twenty-eight (25%) patients were tracheostomy-tube depen-
dent on presentation. Past treatments included tracheostomy
in 48 (42%), endoscopic laser resection or dilatation was per-
formed in 68 (60%), and open resection in 23 (20%) patients.
Stenosis Characteristics
All patients underwent thorough preoperative evalu-
ation with autoimmune workup, computed tomography
scanning, and an endoscopic examination under general
anesthesia. A biopsy was taken for histopathological
examination in all cases to exclude either an inflamma-
tory process or malignancy. Patients with autoimmune
etiology were not offered CTR. The subglottis was the sole
site of stenosis in 91 (80%) patients, two (2%) had upper
tracheal stenosis, and combined stenosis (i.e., glottis and
subglottis) was reported in 21 (18%) cases. Using the
Cotton-Myer staging classification, grade I stenosis was
present in 43 (43%) patients, grade II in 32 (32%), grade
III in 21 (21%), and grade IV in five (5%) patients. Accu-
rate records of the grade of stenosis were missing in
13 patients. The mean length of stenosis was 2.2 cm
(SD = 0.7, median 2 [1–4.5]).
Treatment Characteristics
Sixty-two (54%) patients underwent a CTR and
TTA, and 52 (46%) patients underwent a CTR and TTA
with additional laryngofissure as previously described by
Pearson and Gullane.1
The mean length resected was 2.9 cm (SD = 0.7 cm,
median = 3 cm [1–5 cm]). Postoperative airway patency
was maintained via a T tube in 92 (81%) and a tracheos-
tomy in eight cases (7%). The mean time with a T tube
(TTtime) was 65.1 days [SD = 140.3 days, median = 43 days
[0–1451]). A permanent tracheostomy was necessary in
six (5%) patients.
Major complications occurred in 16 patients (14%), and
minor complications in 20 (18%) patients. Restenosis requir-
ing active intervention occurred in 15 patients (13%).
Univariable Analysis of Restenosis
Medical comorbidity (odds ratio [OR] = 3.2, P = .039),
prior external procedure (OR = 3.2, P = .048), postopera-
tive minor complication (OR = 7.9, P = .002), and need for
repeat surgery (OR = 95.0, P < .001) were associated with
increased risk of restenosis (Table II).
Univariable Analysis of Permanent
Tracheostomy
Traumatic stenosis (OR = 10.3, P = .017), longer T-tube
duration (OR = 1.2, P = .011), combined glottic/subglottic
stenosis (OR = 10.47, P = .010), start of the stenosis at the
vocal cords (OR = 6.6, P = .029), postoperative minor compli-
cations (OR = 13.6, P = .028), and need for repeat surgery
(OR = 44.1, P < .001) were associated with an increased risk
of requiring permanent tracheostomy (Table II).
Univariable Analysis of Composite Outcome
(Restenosis and Permanent Tracheostomy)
Medical comorbidity (OR = 3.8, P = .017), combined
glottic/subglottic stenosis (OR = 3.24, P = .046), grade
2 stenosis (OR = 4.4, P = .040), postoperative minor com-
plication (OR = 9.7, P < .001), and need for repeat surgery
(OR = 137.2, P < .001) were associated with an increased
risk of restenosis and permanent tracheostomy (Table II).
Overall, 108 patients (95%) were successfully decan-
nulated. These patients achieved an excellent result in terms
of upper aerodigestive tract function satisfactory for all of
their activities of daily living.
DISCUSSION
The primary goal of management in patients with
subglottic stenosis is to reestablish a functional airway.
Management options include dilatation, endoscopic laser
resection, laryngofissure, laryngotracheoplasty, and CTR
( laryngofissure) with TTA.8–14 Circumferential resection of
the upper airway has been described as early as Ogura and
Biller in 19719 andGerwat andBryce in 1974.10 The combined
thoracic and head and neck surgical approach has allowed
refinement of this technique, which today is well accepted as
an excellent option for the treatment of both glottic and sub-
glottic stenosis. These successes have been substantiated by
contemporary reports from Pearson et al. (1986), Grillo et al.
(1992), and Courard et al. (1988).11–13 Hartley and Cotton
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(2000) and Monnier et al. (1993) have also demonstrated the
successful application of this technique for the treatment of
pediatric subglottic stenosis.15,16
The management principles in CTR and TTA include
complete resection of the pathology, repair and reconstruc-
tion of the airway, maintaining the repair to allow healing,
and finally successful decannulation. A number of factors are
important and can be conveniently divided into patient, dis-
ease, and treatment related. Patient comorbidity plays a
major role in determining the ability to heal after surgery.
The presence of medical comorbidities in this series was a
significant risk factor for restenosis on univariable analysis.
There are limited data investigating predictors of decan-
nulation failure after tracheostomy. However, Fiz et al. dem-
onstrated that airway comorbidities (asthma, COPD,
unilateral vocal cord paralysis), postoperative complications,
and length of resection are risk factors for retreatment.5 We
also demonstrated that postoperative minor complications
were associated with both restenosis and permanent trache-
ostomy. However, we did not demonstrate that length of
resection was a risk factor for restenosis or permanent tra-
cheostomy. Postoperative complications may cause wound-
healing issues that disruptmaintenance of the repair.
A history of airway trauma was significant on
univariable analysis in predicting the likelihood of per-
manent tracheostomy. Patients with a history of airway
trauma may have more cartilaginous and soft tissue
damage, which can make the reconstruction more chal-
lenging and the healing process more tenuous. Need for
repeat surgery was associated with permanent tracheos-
tomy and restenosis on univariable analysis. Stenosis
beginning at the level of the vocal cords was associated
with permanent tracheostomy. Similarly, combined glottic/
subglottic stenosis was associated with a higher risk of
permanent tracheostomy. In pediatric patients, Monnier
also demonstrated that glottic involvement was associ-
ated with less favorable outcomes.6 Monnier also demon-
strated that severe stenosis and comorbidities were
associated with a less favorable outcome.
The surgical steps when performing CTR  laryn-
gofissure and TTA have been detailed previously.1,17 The
key features of this technique include minimal posterolat-
eral dissection of the trachea to preserve an adequate vascu-
lar supply. Adequate mobilization anterior to the trachea
can be safely carried out with blunt dissection to the level of
the aortic arch in most patients. This allows a tension-free
repair in the majority of cases. We do not perform a laryn-
geal release, as we feel that this can lead to significant prob-
lems with dysphagia, which in some patients may be
permanent. Our experience has shown that with the current
approach we are able to safely resect up to 5 cm of trachea
without any significant problems. This is more than ade-
quate because the majority of lesions in our series required
approximately 3 cm of airway resection (range, 1–5 cm).
Additionally, neither length of resection or length of stenosis
was associatedwith permanent tracheostomy or restenosis.
We prefer to stent the upper airway in all patients
undergoing CTR. The aim of this is to maintain the repair
and allow unimpeded healing without restenosis. There are a
number of options available. On occasion we have used solid
intralaryngeal stents covered with a distal tracheostomy.
However, we prefer using a soft, Silastic T tube, which allows
normal respiration and phonation. In addition, the T tube
permits occasional toilet of the lower airway. The majority of
patients experience some degree of temporary aspiration,
which settles with conservative management. We aim to
remove the T tube at 6 to 8 weeks postoperatively; however,
the precise time required is controversial and still debated
in the literature. In this study, longer T-tube duration was
associated with a higher risk of permanent tracheostomy.
Patients with extensive subglottic stenosis, combined
glottic/subglottic stenosis, or significant comorbidities in our
experience require a prolonged period of airway stenting. It is
possible that the duration of T-tube stenting acts as a surro-
gate marker for these factors in determining outcome after
CTR rather than stenting actually leading to an increased
failure rate.
CTR and TTA are complex procedures that are not
without risks. We experienced complications (major = 16,
minor = 20) in 36 patients. The majority of these were
easily managed and reversible. Development of complica-
tions was a significant predictor of permanent tracheos-
tomy and restenosis in this study. Restenosis requiring
further management occurred in 15 (13%) patients. Ulti-
mately, we were unable to decannulate six (5%) patients
after either primary CTR or salvage surgery.
The major limitation of this study is the small sam-
ple size. First of all, the sample size of restenosis and per-
manent tracheostomy is small. Given this, we were not
able to do statistical analysis with sufficient power on
each variable of interest. For example, we could not do
analysis of comorbidity or degree of stenosis in the per-
manent tracheostomy group. Although history of trauma
was a significant predictor of permanent tracheostomy,
only seven (6%) patients had airway trauma in this
cohort, which limits the analysis. We were able to over-
come some of these limitations by combining groups. We
created a composite cohort of patients with restenosis and
permanent tracheostomy that could allow us to do statis-
tical analysis. Only five patients had grade 4 stenosis,
which limits effective analysis. Thus, we combined grade
3 and 4 stenosis in the univariable analysis.
Alternative outcome measures were not included in
this retrospective analysis but are equally vital in mea-
suring the success of the management of subglottic steno-
sis, including physiologic measures of airway resistance
(i.e., flow volume loops, body plethysmography), voice analy-
sis, and quality-of-life measures. It is our belief that voice
outcomes are good in themajority of patients given the debil-
itating nature of chronic airway obstruction. The majority of
patients undergo significant frame-shift with respect to
voice quality, where the ability to carry out activities of daily
living without any airway limitation takes on greater impor-
tance when compared to obtaining a normal voice. This in
part explains our clinical observations; however, prospective
quality-of-life measures, using both general and specific
instruments (i.e., 36-item Short Form Health Survey and
Voice Handicap Index) addressing this issue are needed to
confirm this.18 Future research activity needs to focus on the
underlying physiological and molecular factors that predis-
pose some patients to the development of clinically signifi-
cant upper airway stenosis.
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CONCLUSION
Subglottic stenosis is a heterogeneous and complex
clinical entity that provides significant challenges for
both the patient and the treating physician. A number of
management strategies have been reported in the litera-
ture; however, there does not currently exist a uniform
approach to this complex problem. We present our experi-
ence with CTR and TTA and identified a number of
adverse prognostic factors predicting the need for a per-
manent tracheostomy. Traumatic stenosis, longer T-tube
duration, combined glottic/subglottic stenosis, start of ste-
nosis at the vocal cords, postoperative minor complica-
tions, and need for repeat surgery were associated
with an increased risk of requiring permanent tracheos-
tomy. In summary, 108 patients (95%) were successfully
decannulated after undergoing CTR and TTA. Our per-
manent tracheostomy rate of 5% confirms other publica-
tions reporting the excellent outcome achieved with this
technique for the definitive management of subglottic ste-
nosis. CTR with or without laryngofissure is our standard
of care in patients with subglottic stenosis.
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